|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
|
|---|---|---|
| Revenues | ||
| Cost of revenues | ||
| Gross profit | ||
| Operating expenses: | ||
| Sales and marketing | ||
| General and administrative | ||
| Product development | ||
| Employee cost | ||
| Total operating expenses | ||
| Income (loss) from operations | ||
| Other income (expense), net: | ||
| Interest income | ||
| Other Income | ||
| Foreign exchange gain/(loss) | ||
| Interest expense | ||
| Total other income (expense), net | ||
| Income (loss) before benefit/(provision) for taxes | ||
| Income tax benefit/(provision) | ||
| Deferred tax asset / (liability) | ||
| Net income | ||
| Less: Net loss attributable to non-controlling interests | ||
| Net income attributable to stockholders | ||
| Earnings per share basic | ||
| Earnings per share diluted | ||
| Weighted average common shares outstanding - basic | ||
| Weighted average common shares outstanding - diluted | ||
| Other comprehensive income (loss): | ||
| Foreign currency translation adjustment | ||
| Total other comprehensive income, net of tax | ||
| Comprehensive income (loss) | ||
| Less: Comprehensive loss attributable to non-controlling interests | ||
| Comprehensive income attributable to stockholders |
Loading...
